echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Retention needles, infusions... Low-value consumables provincial belt procurement is coming

    Retention needles, infusions... Low-value consumables provincial belt procurement is coming

    • Last Update: 2020-12-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Medical network December 17th, following the high-value medical supplies to open the national and provincial level of the volume of procurement, low-value supplies collection will also come! Recently, the Hebei Provincial Medical Security Bureau issued the "Hebei Province medical supplies centralized belt procurement documents (one-time use of infusions and intravenous retention needles) " (draft for comments).
    can save us a small retention needle and an infusion after the collection is turned on? Hebei sent a message to solicit ideas: one-time use of infusions also need to take the volume of procurement! According to the draft for comments issued by the Hebei Provincial Medical Security Bureau, hebei's main procurement is public medical institutions and military medical institutions in Hebei Province.
    in accordance with the draft for comments, the agreed procurement volume according to the "price minimum products accounted for the main agreed procurement volume, other selected products agreed procurement volume in accordance with the price from low to high gradually reduced" distribution principle.
    non-selected products are all included in the hebei Province medical drug equipment procurement center monitoring and management, according to its price gap with the selected products (or similar products), further reduce the price, and examine and assess the clinical rational use.
    addition, non-selected products included in the monitoring catalogue shall not purchase more than the remaining purchases.
    fact, as early as July 2019, the General Office of the State Council issued the "Management of high-value medical supplies reform program."
    , high-value medical supplies concentrated with volume procurement in Anhui, Jiangsu and other provinces to break the ice.
    november this year, high-value medical supplies national mining opened.
    , at present, most of the provincial level belt procurement to high-value consumables mainly, and low-value consumables belt procurement to the city-level alliance as the main force.
    For example, at the beginning of this year, Shanxi city health insurance departments from the one-time use of medical supplies, respectively, the choice of intravenous retention needles, hemodialysis devices, disposable infusions and other low-value medical supplies, carried out a centralized volume procurement negotiations bargaining pilot work.
    11 cities in the province have fully realized through the formation of municipal alliances to carry out drug supplies belt procurement.
    Xuzhou, Jiangsu Province, last September organized the city's 25 public medical institutions to form a medical supplies sunshine procurement alliance, orthopaedic needles, disposable casing punctures and other municipal tube medical supplies to carry out volume procurement price negotiations.
    this time, Hebei Province at the provincial level to carry out low-value consumables with volume procurement, whether the future procurement from the city-based to provincial-based signal, has become the focus of attention.
    can low-value consumables tape procurement save patients? Low-value medical supplies can be subdivided into medical hygiene materials and dressings, injection punctures, medical polymer materials, medical disinfection, and so on.
    although the price of low-value medical supplies is not expensive, but compared with high-value medical supplies, low-value medical supplies are widely used.
    , the domestic market for low-value medical supplies in 2019 was 77 billion yuan, up 20.12% year-on-year.
    , how much money can be saved by purchasing small infusions and retention needles with volume? Practice in some areas has given the answer.
    yueyang, Hunan Province, in July this year, the city's low-value medical supplies and inspection reagents centralized procurement projects have been completed.
    through recruitment, a total of 1042 selected suppliers, a total of 20,684 selected products, the overall price decline reached 11.7%, some enterprises single-use intravenous retention needles fell by as much as 83.6%.
    Again, in Shanxi, for example, according to data released by Shanxi's medical insurance department, the average reduction in the volume of the first batch of low-value medical supplies concentrated in 11 cities in Shanxi Province is more than 55%, which is expected to save hundreds of millions of yuan in related supplies in one year.
    can be seen, for low-value medical supplies with the purchase of the volume, will certainly save patients not a small amount of money.
    drug consumption information bank, credit "blacklist"... The state cut off the profit transmission from drugs to high-value consumables, to low-value consumables ... In recent years, the pace of exploration of volume procurement at the national and local levels has accelerated.
    at the national level, just last month, the "slash price" of the heart stent, the opening of the first collection of high-value consumables, caused a high degree of concern.
    crown vein bracket price from the previous average price of about 13,000 yuan to about 700 yuan, can be said to open the "floor price."
    based on the amount of intentional procurement, the collection is expected to save 10.9 billion yuan.
    local level, including Jiangsu, Hainan and many other provinces have also started to actively "group procurement", some high-value medical supplies prices fell by an average of more than 50%.
    , of course, this is only the beginning, follow-up collection is already on the road, perfect data support and regulatory measures are also followed.
    , for example, the health-care sector has made positive progress in establishing a unified national database on drug consumption.
    According to the State Health Insurance Administration previously introduced, the State Health Insurance Administration relying on the medical security information platform to build a rapid collection of drugs and medical supplies function module system (referred to as the fast mining system), through the fast mining system to build a unified national centralized drug procurement information base, has collected the 2019 national provinces, hospitals drug transaction prices and transaction volume, which will provide data support for price linkage work.
    In addition, previously, the State Health Insurance Administration also issued the "Pharmaceutical Price and Credit Evaluation Operating Code (2020 Edition)", clearly will be in the pharmaceutical and medical supplies centralized procurement, platform network, and in public medical institutions and medical insurance fixed-point non-public medical institutions in the record procurement of the establishment of pharmaceutical prices and credit evaluation system.
    Pharmaceutical enterprises will face written reminders and warnings, relying on centralized procurement platform to remind buyers of risk information, limit or suspend the relevant drugs or medical supplies hanging on the network, limit or suspend the procurement of related drugs or medical supplies, disclosure of disincance information and other disposal measures, misinrepishment involving the number of provinces to meet the prescribed conditions, will also be initiated by the State Health Insurance Administration pharmaceutical prices and tender procurement guidance center national joint disposal.
    in the industry, with the national volume of procurement, more and more drugs and equipment are included in the scope of procurement.
    the emergence of credit evaluation policy, on the other hand, can effectively control the pharmaceutical rebates and sales with gold and other long-standing shortcomings of the pharmaceutical industry, so that patients enjoy real benefits in the future.
    (Complete)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.